Status:
UNKNOWN
Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborating Sponsors:
Zhejiang Xingyue Biotechnology Co., Ltd.
Conditions:
Rotator Cuff Tear
Lateral Epicondylitis
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
This study was a single-center, randomized, single-blind clinical trial. We plan to include 100 patients who met exclusion criteria of rotator cuff and lateral epicondylosis (tennis elbow) respectivel...
Detailed Description
All injection will be done under ultrasound guidance.
Eligibility Criteria
Inclusion
- clinically diagnosed as rotator cuff tear or lateral epicondylitis (tennis elbow);
- symptom duration is over 3 months, non-steroidal drug treatment , rehabilitation treatment and other conservative treatment is invalid;
- patient that can understand the clinical trials and signed the informed consent.
Exclusion
- patient that underwent other injection treatment within 6 weeks
- some associated diseases (such as arthritis, synovitis, entrapment of related nerve, radiculopathy to the target lesion, generalized pain syndrome, rheumatoid arthritis, pregnancy, impaired sensibility, paralysis, history of allergic or hypersensitive reaction to bovine-derived proteins or fibrin glue)
- patient that enrolled other clinical trials within 3 months
- history of drug/alcohol addiction, habitual smoker
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03279796
Start Date
October 1 2018
End Date
December 31 2021
Last Update
April 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weiliang Shen
Hangzhou, Zhejiang, China, 310058